As Volkow et al. showed that ADHD patients present reductions in DAT and D2/3 receptor levels in the VS59, so we confirm that this structure plays a key role in the therapeutic effects of MPH on impulsivity. This evidence concerns the gene SLC6A3 and attention deficit-hyperactivity disorder.